Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma

The objective of this study was to further investigate the efficacy and safety of low-dose outpatient chemobiotherapy in patients with unresectable metastatic melanoma. Thirty-one patients with histologically confirmed unresectable measurable metastatic melanoma were enrolled onto an open-label, mul...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2005-12, Vol.23 (35), p.8992
Hauptverfasser:	Weber, Robert W, O'Day, Steven, Rose, Madalene, Deck, Regina, Ames, Patricia, Good, James, Meyer, John, Allen, Robert, Trautvetter, Sharon, Timmerman, Molly, Cruickshank, Scott, Cook, Mary, Gonzalez, Rene, Spitler, Lynn E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Ambulatory Care Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Dacarbazine - administration & dosage Dacarbazine - analogs & derivatives Disease Progression Female Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage Humans Interferon-alpha - administration & dosage Interleukin-2 - administration & dosage Male Melanoma - drug therapy Melanoma - immunology Melanoma - pathology Middle Aged Neoplasm Staging Recombinant Proteins Survival Analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!